128 related articles for article (PubMed ID: 16112111)
1. Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness.
Matteucci E; Locati M; Desiderio MA
Exp Cell Res; 2005 Oct; 310(1):176-85. PubMed ID: 16112111
[TBL] [Abstract][Full Text] [Related]
2. HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB.
Maroni P; Bendinelli P; Matteucci E; Desiderio MA
Carcinogenesis; 2007 Feb; 28(2):267-79. PubMed ID: 16840440
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
Lee BC; Lee TH; Avraham S; Avraham HK
Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
[TBL] [Abstract][Full Text] [Related]
4. c-Src/histone deacetylase 3 interaction is crucial for hepatocyte growth factor dependent decrease of CXCR4 expression in highly invasive breast tumor cells.
Matteucci E; Ridolfi E; Maroni P; Bendinelli P; Desiderio MA
Mol Cancer Res; 2007 Aug; 5(8):833-45. PubMed ID: 17699109
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.
Phillips RJ; Mestas J; Gharaee-Kermani M; Burdick MD; Sica A; Belperio JA; Keane MP; Strieter RM
J Biol Chem; 2005 Jun; 280(23):22473-81. PubMed ID: 15802268
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs.
Ridolfi E; Matteucci E; Maroni P; Desiderio MA
Br J Cancer; 2008 Nov; 99(10):1623-34. PubMed ID: 18941460
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.
Staller P; Sulitkova J; Lisztwan J; Moch H; Oakeley EJ; Krek W
Nature; 2003 Sep; 425(6955):307-11. PubMed ID: 13679920
[TBL] [Abstract][Full Text] [Related]
8. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
10. New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation.
Jin F; Brockmeier U; Otterbach F; Metzen E
Mol Cancer Res; 2012 Aug; 10(8):1021-31. PubMed ID: 22767589
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines.
Tacchini L; De Ponti C; Matteucci E; Follis R; Desiderio MA
Carcinogenesis; 2004 Nov; 25(11):2089-100. PubMed ID: 15240510
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.
Gu Q; He Y; Ji J; Yao Y; Shen W; Luo J; Zhu W; Cao H; Geng Y; Xu J; Zhang S; Cao J; Ding WQ
Oncotarget; 2015 May; 6(13):10893-907. PubMed ID: 25843954
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
Helbig G; Christopherson KW; Bhat-Nakshatri P; Kumar S; Kishimoto H; Miller KD; Broxmeyer HE; Nakshatri H
J Biol Chem; 2003 Jun; 278(24):21631-8. PubMed ID: 12690099
[TBL] [Abstract][Full Text] [Related]
14. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
[TBL] [Abstract][Full Text] [Related]
15. CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways.
Lian X; Jiao Y; Yang Y; Wang Z; Xuan Q; Liu H; Lu S; Wang Z; Liu Y; Li S; Yang Y; Guo L; Zhao L; Zhang Q
Med Oncol; 2015 Jan; 32(1):411. PubMed ID: 25476480
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration.
Lee BC; Lee TH; Zagozdzon R; Avraham S; Usheva A; Avraham HK
Cancer Res; 2005 Apr; 65(7):2840-5. PubMed ID: 15805285
[TBL] [Abstract][Full Text] [Related]
17. HGF-induced PKCζ activation increases functional CXCR4 expression in human breast cancer cells.
Huang S; Ouyang N; Lin L; Chen L; Wu W; Su F; Yao Y; Yao H
PLoS One; 2012; 7(1):e29124. PubMed ID: 22242160
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
19. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract][Full Text] [Related]
20. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
Hwang JH; Hwang JH; Chung HK; Kim DW; Hwang ES; Suh JM; Kim H; You KH; Kwon OY; Ro HK; Jo DY; Shong M
J Clin Endocrinol Metab; 2003 Jan; 88(1):408-16. PubMed ID: 12519884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]